Figure 3

Representative phenotypic profiles of % CD4⁺CD25⁺CD127^-FOXP3⁺Tregs in good pathological responders (Groups I and II), 200,000 events acquired, and poor pathological responders (Groups III and IV), 200,000 events acquired. AbNs of monocytic (CD11b⁺ CD14⁺ HLA DR^- CD124⁺ CD33⁺) MDSCs, in good pathological responders (Groups I and 11) 400,000 events acquired, and AbNs of granulocytic (CD11b⁺ CD14^- CD66b⁺ CD124⁺ CD15⁺) MDSCs in good pathological responders (Groups I and II), 150,000 events acquired. Data shown are for women with LLABCs, (baseline, post-chemotherapy, post-surgery) and healthy donors.